Untitled timeline


Andersen Patent decision

Approx. 2010

Federal jury ruled that Medtronic CoreValve LLC willfully infringed on the U.S. Andersen transcatheter heart valve patent, owned by Edwards. Damages were awarded to Edwards

FDA approves Edwards Sapien valve

November 2011

FDA approves Edwards Sapien valve

Medtronic pays initial damages


Medtronic pays Edwards $84 million in initial damages for pending case

Results CoreValve US Pivotal Trial presented

October 2013

CoreValve U.S. pivotal trial data presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) conference. This trial’s first results were very positive. For patients in which traditional open-heart surgery was too much of a risk, the CoreValve system showed to reduce the rate of death or major stroke by 40.7% compared to patients treated with standard therapy.

Cribier patent decision in favor of Edwards

January 15, 2014

Jury in Federal District Court of Delaware decides the Medtronic CoreValve infringes on Edwards’ U.S. Cribier transcatheter heart valve patent (U.S. Pat. No. 8,002,825). Edwards was awarded $394 million in damages. Medtronic moves to appeal decision

FDA approves CoreValve for inoperable patients

January 17, 2014

FDA approval of CoreValve System for inoperable patients after review of U.S. Pivotal trial

Injunction on sale of CoreValve issued

April 14, 2014

Injunction issued by federal court barring Medtronic from selling recently approved CoreValve product

Injunction decision postponed

April 21, 2014

Injunction decision postponed

Settlement of Medtronic v Edwards

May 20, 2014

Global patent license settlement between Medtronic and Edwards. All pending litigation matters and patent office actions dismissed by both parties, Medtronic will pay Edwards $750 million, along with ongoing royalty payments of no less than $40 million annually until April 2022. Both parties agreed that they will not sue each other for patent matters anywhere in the world for eight years in the field of aortic and other transcatheter heart valves